IND : +917498085685
US : +1-607-821-7755
  • Home
  • » Pharmaceuticals
Pharmaceuticals

Published: May, 2019 |  131 Pages  |  Publisher: LP Information
Notoginseng root extract is derived from the root of the notoginseng plant. Notoginseng is an herb primarily grown for blood - circulation related issues. According to this study, over the next five years the Notoginseng Root Extract market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Notoginseng Root Extract business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Notoginseng Root Extract market by product type, application, key manufacturers and key regions and countries. This study considers the Notoginseng Root Extract value and volume generated from the sales of the following segments: Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7. Powder Extract Liquid Extract Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8. Pharmaceuticals Cosmetics and Personal Care Health Supplement Products Others This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Spain Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3. Organic Herb Inc Xi''an KinGreen Bio - Engineering Technology Sichuan Xingjiexiang Pharmaceutical Xi''an Qing Zhi Biotechnology Nanjing NutriHerb BioTech ... In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development. Research objectives To study and analyze the global Notoginseng Root Extract consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024. To understand the structure of Notoginseng Root Extract market by identifying its various subsegments. Focuses on the key global Notoginseng Root Extract manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Notoginseng Root Extract with respect to individual growth trends, future prospects, and their contribution to the total market. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry - specific challenges and risks). To project the consumption of Notoginseng Root Extract submarkets, with respect to key regions (along with their respective key countries). To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies. Read More »
Published: May, 2019 |  136 Pages  |  Publisher: LP Information
ADH is a hormone stored in the posterior pituitary gland in the brain, regulating water levels in the body. ADH interacts with the kidneys to increase total body water increasing blood volume and blood pressure. The release of ADH is controlled by cells called osmoreceptors and baroreceptors. According to this study, over the next five years the Antidiuretic Hormone (ADH) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Antidiuretic Hormone (ADH) business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Antidiuretic Hormone (ADH) market by product type, application, key manufacturers and key regions and countries. This study considers the Antidiuretic Hormone (ADH) value and volume generated from the sales of the following segments: Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7. Intravenous Injection Intramuscular Injection Subcutaneous Injection Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8. Anti - Diuretic Hormone Deficiency Vasodilatory Shock Gastrointestinal Bleeding Ventricular Tachycardia & Fibrillation This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Spain Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3. Novartis Pfizer Fresenius Kabi Par Pharmaceutical Ferring Pharmaceuticals Astellas Pharma Shanghai Soho - Yiming Pharmaceuticals ... In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development. Research objectives To study and analyze the global Antidiuretic Hormone (ADH) consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024. To understand the structure of Antidiuretic Hormone (ADH) market by identifying its various subsegments. Focuses on the key global Antidiuretic Hormone (ADH) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Antidiuretic Hormone (ADH) with respect to individual growth trends, future prospects, and their contribution to the total market. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry - specific challenges and risks). To project the consumption of Antidiuretic Hormone (ADH) submarkets, with respect to key regions (along with their respective key countries). To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies. Read More »
Published: May, 2019 |  135 Pages  |  Publisher: LP Information
North America has remained a lucrative market for algae supplements, underpinned in part by the burgeoning demand for algae - based products in the region. APAC is likely to emerge as a high - growth market for algae supplements, upheld by evolving consumer lifestyles and changing dietary patterns across emerging economies in the region. According to this study, over the next five years the Algae Supplements market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Algae Supplements business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Algae Supplements market by product type, application, key manufacturers and key regions and countries. This study considers the Algae Supplements value and volume generated from the sales of the following segments: Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7. Capsules Algae Supplements Powder & Granules Algae Supplements Liquids Algae Supplements Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8. Supermarkets and Hypermarkets Drug Stores Health & Beauty Stores Online Retailers This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Spain Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3. Now Foods Daesang (Chlorella Supply) Nature''s Way Products Pharmavite LLC Cyanotech Corporation Parry Nutraceuticals Fuqing King Dnarmsa Spirulina Xiamen Kingdomway Group (Doctor''s Best) In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development. Research objectives To study and analyze the global Algae Supplements consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024. To understand the structure of Algae Supplements market by identifying its various subsegments. Focuses on the key global Algae Supplements manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Algae Supplements with respect to individual growth trends, future prospects, and their contribution to the total market. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry - specific challenges and risks). To project the consumption of Algae Supplements submarkets, with respect to key regions (along with their respective key countries). To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies. Read More »
Published: May, 2019 |  133 Pages  |  Publisher: LP Information
Folinic acid, also known as leucovorin, is a medication used to decrease the toxic effects of methotrexate and pyrimethamine. According to this study, over the next five years the Folinic Acid market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Folinic Acid business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Folinic Acid market by product type, application, key manufacturers and key regions and countries. This study considers the Folinic Acid value and volume generated from the sales of the following segments: Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7. Injection Tablets Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8. Hospital Pharmacies Retail Pharmacies Online Pharmacies This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Spain Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3. Pfizer Eli Lilly Hikma Pharmaceuticals Sagent Pharmaceuticals Jiangsu Hengrui Medicine ... In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development. Research objectives To study and analyze the global Folinic Acid consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024. To understand the structure of Folinic Acid market by identifying its various subsegments. Focuses on the key global Folinic Acid manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Folinic Acid with respect to individual growth trends, future prospects, and their contribution to the total market. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry - specific challenges and risks). To project the consumption of Folinic Acid submarkets, with respect to key regions (along with their respective key countries). To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies. Read More »
Published: May, 2019 |  139 Pages  |  Publisher: LP Information
Clinical nutrition products are specially formulated to nourish and improve the quality of life for people of all ages. According to this study, over the next five years the Clinical Nutritional Supplements market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Clinical Nutritional Supplements business, shared in Chapter 3. This report presents a comprehensive overview, market shares and growth opportunities of Clinical Nutritional Supplements market by product type, application, key companies and key regions. This study considers the Clinical Nutritional Supplements value generated from the sales of the following segments: Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7. Liquid Supplements Semi - Solid Supplements Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8. Paediatric Adult Geriatric This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Spain Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3. Medline Industries Baxter B. Braun Melsungen Fresenius Kabi Otsuka Pharmaceutical Abbott Laboratories Nutricia GlaxoSmithKline Pfizer Perrigo Nature Read More »
Published: May, 2019 |  158 Pages  |  Publisher: LP Information
Oral clinical nutritional supplements are sterile liquids, semi - solids or powders, which provide macro and micro nutrients. According to this study, over the next five years the Oral Clinical Nutritional Supplements market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Oral Clinical Nutritional Supplements business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Oral Clinical Nutritional Supplements market by product type, application, key manufacturers and key regions and countries. This study considers the Oral Clinical Nutritional Supplements value and volume generated from the sales of the following segments: Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7. Liquid Supplements Semi - Solid Supplements Powder Supplements Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8. Paediatric Adult Geriatric This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Spain Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3. Medline Industries Baxter B. Braun Melsungen Fresenius Kabi Otsuka Pharmaceutical Abbott Laboratories Nutricia GlaxoSmithKline Pfizer Perrigo Nature Read More »
Published: May, 2019 |  167 Pages  |  Publisher: LP Information
Diindolylmethane is a natural substance generated when the body breaks down indole - 3 - carbinol, a compound found in cruciferous vegetables such as broccoli and kale. According to this study, over the next five years the Diindolylmethane market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Diindolylmethane business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Diindolylmethane market by product type, application, key manufacturers and key regions and countries. This study considers the Diindolylmethane value and volume generated from the sales of the following segments: Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7. Organic Diindolylmethane Conventional Diindolylmethane Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8. Hospital Pharmacies Drug Stores Retail Pharmacies Online Pharmacies This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Spain Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3. NOW Foods Source Naturals Nature Read More »
Published: May, 2019 |  132 Pages  |  Publisher: LP Information
A migraine is an episodic and unpredictable headache disorder that presents with disabling attack. Acute medications fall into general classes of medicines including analgesics, ergotamines and triptans. According to this study, over the next five years the Acute Migraine Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Acute Migraine Drugs business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Acute Migraine Drugs market by product type, application, key manufacturers and key regions and countries. This study considers the Acute Migraine Drugs value and volume generated from the sales of the following segments: Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7. Nonsteroidal Anti - Inflammatory Drugs Triptans Dihydroergotamine Nonspecific Migraine Medications Analgesics Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8. Hospital Pharmacies Drug Stores Retail Pharmacies Online Pharmacies This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Spain Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3. Amgen Pfizer Novartis Eli Lily AstraZeneca Teva Pharmaceutical Allergan Abbott In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development. Research objectives To study and analyze the global Acute Migraine Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024. To understand the structure of Acute Migraine Drugs market by identifying its various subsegments. Focuses on the key global Acute Migraine Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Acute Migraine Drugs with respect to individual growth trends, future prospects, and their contribution to the total market. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry - specific challenges and risks). To project the consumption of Acute Migraine Drugs submarkets, with respect to key regions (along with their respective key countries). To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies. Read More »
Published: May, 2019 |  159 Pages  |  Publisher: LP Information
Squalane oil comes from squalene, squalene is part of our skin Read More »
Published: May, 2019 |  130 Pages  |  Publisher: LP Information
Hash oil, also known as honey oil or cannabis oil, is an oleoresin obtained by the extraction of cannabis or hashish. It is a concentrated form of cannabis extracts containing many of its resins and terpenes - in particular, tetrahydrocannabinol (THC), cannabidiol (CBD), and other cannabinoids. According to this study, over the next five years the Hash Oil market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Hash Oil business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Hash Oil market by product type, application, key manufacturers and key regions and countries. This study considers the Hash Oil value and volume generated from the sales of the following segments: Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7. Organic Type Non - Organic Type Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8. Recreational Medical This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Spain Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3. Select Oil K.I.N.D. Concentrates Canopy Growth Corporation Aphria Emblem Cannabis Oils Whistler The Lab Absolute Terps In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development. Research objectives To study and analyze the global Hash Oil consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024. To understand the structure of Hash Oil market by identifying its various subsegments. Focuses on the key global Hash Oil manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Hash Oil with respect to individual growth trends, future prospects, and their contribution to the total market. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry - specific challenges and risks). To project the consumption of Hash Oil submarkets, with respect to key regions (along with their respective key countries). To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies. Read More »
Published: May, 2019 |  135 Pages  |  Publisher: LP Information
Cytokinins are plant hormones that help in growth promoting cell division in plant shoots and roots. These growth substances are used in various end - user industries such as pharmaceutical, agricultural, biomedicine and others. Cytokinins impact the apical dominance, leaf senescence, and axillary bud growth as well in plants. Adenine type of cytokinin includes zeatin, kinetin and 6 - benzylaminopurine while phenylurea type of cytokinin includes thidiazuron and diphenylurea. According to this study, over the next five years the Cytokinins market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Cytokinins business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Cytokinins market by product type, application, key manufacturers and key regions and countries. This study considers the Cytokinins value and volume generated from the sales of the following segments: Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7. Adenine - type Phenylurea - type Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8. Agriculture Healthcare Cosmetics Others This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Spain Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3. BASF SE Crop Care Australasia Pvt Ltd. Redox Industries Xinyi Industrial Co. Ltd. Bayer CropScience Sichuan Guoguang Agrochemical Co. Ltd Sigma Aldrich NuFarm Ltd. Monsanto Company In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development. Research objectives To study and analyze the global Cytokinins consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024. To understand the structure of Cytokinins market by identifying its various subsegments. Focuses on the key global Cytokinins manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Cytokinins with respect to individual growth trends, future prospects, and their contribution to the total market. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry - specific challenges and risks). To project the consumption of Cytokinins submarkets, with respect to key regions (along with their respective key countries). To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies. Read More »
Published: May, 2019 |  163 Pages  |  Publisher: LP Information
Prenatal vitamins help to cover nutritional gap during pregnancy. It contains many vitamins and minerals such as iron, calcium and folic acid that are crucial during pregnancy period and also helps baby to get essential nutrients. Folic acids which are present in prenatal vitamins preparations reduce the neural defects such as abnormalities linked to brain and spinal cord. According to this study, over the next five years the Prenatal Vitamins market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Prenatal Vitamins business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Prenatal Vitamins market by product type, application, key manufacturers and key regions and countries. This study considers the Prenatal Vitamins value and volume generated from the sales of the following segments: Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7. Tablets Capsules Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8. Drug store Online Pharmacies Supermarkets Hospital Pharmacies This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Spain Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3. Church & Dwight Country Life Garden of Life Rainbow Light Biotics Research MegaFood Metagenics Nutramark New Chapter Pharmavite Twinlab In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development. Research objectives To study and analyze the global Prenatal Vitamins consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024. To understand the structure of Prenatal Vitamins market by identifying its various subsegments. Focuses on the key global Prenatal Vitamins manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Prenatal Vitamins with respect to individual growth trends, future prospects, and their contribution to the total market. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry - specific challenges and risks). To project the consumption of Prenatal Vitamins submarkets, with respect to key regions (along with their respective key countries). To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies. Read More »
Published: May, 2019 |  136 Pages  |  Publisher: LP Information
Prenatal vitamins preparations help to cover nutritional gap during pregnancy. It contains many vitamins and minerals such as iron, calcium and folic acid that are crucial during pregnancy period and also helps baby to get essential nutrients. Folic acids which are present in prenatal vitamins preparations reduce the neural defects such as abnormalities linked to brain and spinal cord. According to this study, over the next five years the Prenatal Vitamin Preparation market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Prenatal Vitamin Preparation business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Prenatal Vitamin Preparation market by product type, application, key manufacturers and key regions and countries. This study considers the Prenatal Vitamin Preparation value and volume generated from the sales of the following segments: Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7. Tablets Capsules Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8. Drug store Online Pharmacies Supermarkets Hospital Pharmacies This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Spain Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3. FoodState, Inc. Matsun Nutrition Abbott Laboratories Zahler Contract NUTRA Rainbow Light Mission Pharmacal Company ... In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development. Research objectives To study and analyze the global Prenatal Vitamin Preparation consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024. To understand the structure of Prenatal Vitamin Preparation market by identifying its various subsegments. Focuses on the key global Prenatal Vitamin Preparation manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Prenatal Vitamin Preparation with respect to individual growth trends, future prospects, and their contribution to the total market. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry - specific challenges and risks). To project the consumption of Prenatal Vitamin Preparation submarkets, with respect to key regions (along with their respective key countries). To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies. Read More »
Published: May, 2019 |  136 Pages  |  Publisher: LP Information
An anti - inflammatory agent with analgesic and antipyretic properties. Both the acid and its sodium salt are used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea, and acute gout. According to this study, over the next five years the Noproxen market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Noproxen business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Noproxen market by product type, application, key manufacturers and key regions and countries. This study considers the Noproxen value and volume generated from the sales of the following segments: Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7. Powder Granules Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8. Tablet Drug Granules Drug Oral Solution Others This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Spain Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3. Atnahs Pharma Uk Limited Roche Laboratories Inc. Syntex Inc. Apotex Corporation ... In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development. Research objectives To study and analyze the global Noproxen consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024. To understand the structure of Noproxen market by identifying its various subsegments. Focuses on the key global Noproxen manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Noproxen with respect to individual growth trends, future prospects, and their contribution to the total market. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry - specific challenges and risks). To project the consumption of Noproxen submarkets, with respect to key regions (along with their respective key countries). To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies. Read More »
Published: Jan, 2018 |  180 Pages  |  Publisher: Bizwit Research and Consulting
Global Wellness Supplements Market industry valued approximately USD 196.14 billion in 2016 is anticipated to grow with a healthy growth rate of more than 7.49% over the forecast period 2017-2025. The major factors driving the growth are increasing occurrences of long-term diseases, increasing health care prices, escalating elderly population, and growing awareness about advantages of wellness supplements. The objective of the study is to define market sizes of different segments & countries in previous years and to forecast the values to the next eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as drivers & restraining factors which will define the future growth of the market. Additionally, it will also incorporate the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below: Product: ? Dietary Supplements ? Functional/Fortified Food & Beverages ? Food Intolerance ? Dermo-Cosmetic Skin Essentials Regions: ? North America o U.S. o Canada ? Europe o UK o Germany ? Asia Pacific o China o India o Japan ? Latin America o Brazil o Mexico ? Rest of the World Furthermore, the years considered for the study are as follows: Historical year - 2015 Base year - 2016 Forecast period - 2017 to 2025 Some of the key manufacturers involved in the market are Herbalife Ltd., NBTY, Inc., Nestle S.A., Otsuka Holdings Co., Ltd., Abbott Laboratories, Glanbia plc, Amway, and GNC Holdings Inc. New product launches and focuses on continuous technology innovations, acquisitions and effective mergers are certain strategies adopted by the major players. The companies are also trying to dominate the market by investing in research and development. Target Audience of the Wellness Supplements Market Study ? Key Consulting Companies & Advisors ? Large, medium-sized, and small enterprises ? Venture capitalists ? Value-Added Resellers (VARs) ? Third-party knowledge providers ? Investment bankers ? Investors Read More »
Published: Jan, 2018 |  180 Pages  |  Publisher: Bizwit Research and Consulting
Global Pharmaceutical Robots Market industry valued approximately USD 136 million in 2016 is anticipated to grow with a healthy growth rate of more than 14.8% over the forecast period 2017-2025. The major factors driving the growth are escalating numbers of drug discoveries, technological development, and clinical trials. Moreover, the use of automated machines expected to bolster the growth. The objective of the study is to define market sizes of different segments & countries in previous years and to forecast the values to the next eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as drivers & restraining factors which will define the future growth of the market. Additionally, it will also incorporate the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below: Type: ? Traditional Robots o Articulated Robots o SCARA Robots o Delta Robots o Cartesian Robots ? Collaborative Robots Application: ? Picking & Packaging ? Drugs Inspection ? Laboratory Applications Regions: ? North America o U.S. o Canada ? Europe o UK o Germany ? Asia Pacific o China o India o Japan ? Latin America o Brazil o Mexico ? Rest of the World Furthermore, the years considered for the study are as follows: Historical year - 2015 Base year - 2016 Forecast period - 2017 to 2025 Some of the key manufacturers involved in the market are Kawasaki Heavy Industries, Ltd., Denso Wave Inc., ABB Ltd., FANUC America Corp., Seiko Epson Corp., Universal Robots A/S, Marchesini Group S.p.A., and Yaskawa Electric Corp. Investment in research and development, acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and focuses on continuous technology innovations are also strategies adopted by the major players. Target Audience of the Pharmaceutical Robots Market Study ? Key Consulting Companies & Advisors ? Large, medium-sized, and small enterprises ? Venture capitalists ? Value-Added Resellers (VARs) ? Third-party knowledge providers ? Investment bankers ? Investors Read More »
Published: Jan, 2018 |  180 Pages  |  Publisher: Bizwit Research and Consulting
Global Pharmaceutical Packaging Equipment Market industry valued approximately USD 75.58 billion in 2016 is anticipated to grow with a healthy growth rate of more than 6.35% over the forecast period 2017-2025. The major factors driving the growth are globally growing requirements for efficient and superior healthcare services, rising urbanization all around the world, and rising prosperity in the Asia Pacific region. The objective of the study is to define market sizes of different segments & countries in previous years and to forecast the values to the next eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as drivers & restraining factors which will define the future growth of the market. Additionally, it will also incorporate the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below: Package: ? Primary o Blister o Strip o Bottle o Tube o Aseptic Packaging ? Secondary o Wrapping o Case Packaging ? Labelling & Serialization Product: ? Liquid Packaging o Syrup o Aseptic Liquid o Aerosol ? Solid Packaging o Tablets o Powder o Capsules ? Semi-Solid Packaging o Cream o Ointments Regions: ? North America o U.S. o Canada ? Europe o UK o Germany ? Asia Pacific o China o India o Japan ? Latin America o Brazil o Mexico ? Rest of the World Furthermore, the years considered for the study are as follows: Historical year - 2015 Base year - 2016 Forecast period - 2017 to 2025 Some of the key manufacturers involved in the market are Becton, Dickinson & Co., Schott AG, Capsugel Inc., Aptar Group, Inc., Amcor Ltd., Gerresheimer AG, COMAR LLC and Berry Plastics Group. Investment in research and development, acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and focuses on continuous technology innovations are also some strategies adopted by the major players to dominate the market. Target Audience of the Pharmaceutical Packaging Equipment Market Study ? Key Consulting Companies & Advisors ? Large, medium-sized, and small enterprises ? Venture capitalists ? Value-Added Resellers (VARs) ? Third-party knowledge providers ? Investment bankers ? Investors Read More »
Published: Jan, 2018 |  180 Pages  |  Publisher: Bizwit Research and Consulting
Global Ophthalmic Drugs Market industry valued approximately USD 23.21 billion in 2016 is anticipated to grow with a healthy growth rate of more than 5.27% over the forecast period 2017-2025. Rising frequencies of eye disorders like macular degeneration, presbyopia, and diabetic retinopathy among the most prevalent age groups are speculated to propel the growth. The objective of the study is to define market sizes of different segments & countries in previous years and to forecast the values to the next eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as drivers & restraining factors which will define the future growth of the market. Additionally, it will also incorporate the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below: Disease Type: ? Dry Eye Drugs ? Retinal Disorders Drugs ? Ophthalmic Anti-Allergy/Inflammatory/Infective Drugs ? Anti-Glaucoma Drugs Delivery Type: ? Capsules & Tablets ? Gels ? Eye Drops ? Eye Ointment ? Eye Solutions Product Type: ? Prescription Drugs ? Over-the-Counter Drugs Regions: ? North America o U.S. o Canada ? Europe o UK o Germany ? Asia Pacific o China o India o Japan ? Latin America o Brazil o Mexico ? Rest of the World Furthermore, the years considered for the study are as follows: Historical year - 2015 Base year - 2016 Forecast period - 2017 to 2025 Some of the key manufacturers involved in the market are Valeant Pharmaceuticals International, Inc., Sun Pharmaceutical Industries Ltd, Shire Plc, Regeneron Pharmaceuticals, Inc., Alcon, Pfizer Inc., Genentech, Inc., and Santen Pharmaceutical Co., Ltd. New product launches, acquisitions & effective mergers and focuses on continuous technology innovations are some of the strategies adopted by the key manufacturers. The companies are also trying to dominate the market by investing in research and development. Target Audience of the Ophthalmic Drugs Market Study ? Key Consulting Companies & Advisors ? Large, medium-sized, and small enterprises ? Venture capitalists ? Value-Added Resellers (VARs) ? Third-party knowledge providers ? Investment bankers ? Investors Read More »
Published: Jan, 2018 |  180 Pages  |  Publisher: Bizwit Research and Consulting
Global Microencapsulation Market industry valued approximately USD 16.72 billion in 2016 is anticipated to grow with a healthy growth rate of more than 12.1% over the forecast period 2017-2025. The major factor driving the growth is extensive application in numerous industries viz. pharmaceuticals, construction, agrochemicals, personal care products, food industry, etc. for improvising product functionality. The objective of the study is to define market sizes of different segments & countries in previous years and to forecast the values to the next eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as drivers & restraining factors which will define the future growth of the market. Additionally, it will also incorporate the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below: Technology: ? Spray ? Emulsion ? Dripping Core Material: ? Pharmaceutical & Healthcare Drugs ? Food Additives Application: ? Pharmaceuticals ? Food & Beverages Regions: ? North America o U.S. o Canada ? Europe o UK o Germany ? Asia Pacific o China o India o Japan ? Latin America o Brazil o Mexico ? Rest of the World Furthermore, the years considered for the study are as follows: Historical year - 2015 Base year - 2016 Forecast period - 2017 to 2025 Some of the key manufacturers involved in the market are GAT Microencapsulation, Dow Corning Corp., Taste Tech Ltd., BASF, Synthite Industries Ltd., Symrise AG, Givaudan SA, and Lipo Technologies. Acquisitions and effective mergers, new product launches and focus on continuous technology innovations are also some strategies adopted by the key players. The companies are also trying to dominate the market by investing in research and development. Target Audience of the Microencapsulation Market Study ? Key Consulting Companies & Advisors ? Large, medium-sized, and small enterprises ? Venture capitalists ? Value-Added Resellers (VARs) ? Third-party knowledge providers ? Investment bankers ? Investors Read More »
Published: Apr, 2019 |  143 Pages  |  Publisher: Prof Research
Diabetes Drugs Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Diabetes Drugs industry with a focus on the Chinese market. The report provides key statistics on the market status of the Diabetes Drugs manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Diabetes Drugs market covering all important parameters. The key points of the report: 1.The report provides a basic overview of the industry including its definition, applications and manufacturing technology. 2.The report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2014-2019 market shares for each company. 3.Through the statistical analysis, the report depicts the global and Chinese total market of Diabetes Drugs industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export. 4.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis. 5.The report then estimates 2019-2024 market development trends of Diabetes Drugs industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out. 6.The report makes some important proposals for a new project of Diabetes Drugs Industry before evaluating its feasibility. There are 3 key segments covered in this report: competitor segment, product type segment, end use/application segment. For competitor segment, the report includes global key players of Diabetes Drugs as well as some small players. At least 12 companies are included: * Novo Nordisk(US) * Sanofi(DE) * Eli Lilly(UK) * ASTRAZENECA(JP) * Medtronic(IT) * Insulet(US) For complete companies list, please ask for sample pages. The information for each competitor includes: * Company Profile * Main Business Information * SWOT Analysis * Sales, Revenue, Price and Gross Margin * Market Share For product type segment, this report listed main product type of Diabetes Drugs market in gloabal and china. * Product Type I * Product Type II * Product Type III For end use/application segment, this report focuses on the status and outlook for key applications. End users sre also listed. * Application 1 * Application 2 Reasons to Purchase this Report: * Estimates 2019-2024 Diabetes Drugs market development trends with the recent trends and SWOT analysis * Market dynamics scenario, along with growth opportunities of the market in the years to come * Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects * Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market. * Market value (USD Million) and volume (Units Million) data for each segment and sub-segment * Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years * Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players * 1-year analyst support, along with the data support in excel format. Any special requirements about this report, please let us know and we can provide custom report. Read More »